Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
March 25, 2024
In the two years since the John S. Dunn Behavioral Sciences Center at UTHealth Houston opened its doors in collaboration with the Texas Health and Human Services Commission (HHSC), it has helped relieve the overall wait times for Texans needing mental health care and provided a resource closer to home for patients.
March 25, 2024
Working to ensure the safety of nearly 20,000 people on campus on any given day, Scott Patlovich, DrPH, and his team spend their time evaluating risks and ensuring appropriate controls are in place across the many labs, clinics, classrooms, and offices across UTHealth Houston and UT Physicians.
March 20, 2024
UTHealth Houston is among the best employers in the United States, according to the 2024 USA TODAY National Top Workplaces, ranking as the No. 1 university in the country among extra-large institutions.
March 15, 2024
From an Army infantry veteran to a brain cancer survivor, the Class of 2024 at McGovern Medical School at UTHealth Houston found out together today at the Cooley University Life Center where they will take the next steps in their careers.
March 13, 2024
The American Heart Association (AHA) awarded a cumulative $1.2 million to UTHealth Houston School of Public Health researchers to test the effectiveness of Food is Medicine interventions to improve maternal and infant health outcomes.
March 13, 2024
The American Heart Association (AHA) awarded a cumulative $1.2 million to UTHealth Houston School of Public Health researchers to test the effectiveness of Food is Medicine interventions to improve maternal and infant health outcomes.
March 12, 2024
Meet some of the 227 students in the Class of 2024 at McGovern Medical School at UTHealth Houston who will be together on Friday, March 15, to celebrate Match Day, the day when they learn where they will take the next steps in their careers as physicians.
March 6, 2024
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.
March 5, 2024
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.
March 1, 2024
Brian Dean, MBA, MPH, a highly respected health care executive with more than 25 years of experience leading health systems across the country, joins UTHealth Houston as executive vice president for health affairs, effective March 18.
Use the form below to perform a new search.